ReviewFrontiers in pediatrics2020
COVID-19 Pneumonia in Children: From Etiology to Management.
Review in Frontiers in pediatrics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 53 citations in OpenAlex.
- Histopathological examination of lung from infant with lethal COVID-19 with special attention on pneumocytes type II and the immune infiltrate: a case study.Italian journal of pediatrics · 2025Article
- Treatment of Severe Asthma: Case Report of Fast Action of Mepolizumab in a Patient with Recent SARS-CoV-2 Infection.Life (Basel, Switzerland) · 2024Article
- Chest X-ray findings of COVID-19 pneumonia in children: Experiences in a multicenter study in Thailand.PloS one · 2024Article
- Burden of Respiratory Disease in Pediatric Intensive Care Unit: Experience from a PICU of a Tertiary Care Center in Pakistan.Critical care research and practice · 2024Article
- Immune response variation in mild and severe COVID-19 patients.Qatar medical journal · 2024Article
- Characteristics and Risk Factors Associated with SARS-CoV-2 Pneumonias in Hospitalized Pediatric Patients: A Pilot Study.Children (Basel, Switzerland) · 2023Article
- Behavioral and Sleep Disorders in Children and Adolescents following COVID-19 Disease: A Case-Control Study.Children (Basel, Switzerland) · 2023Article
- Assessment of COVID-19 as the Underlying Cause of Death Among Children and Young People Aged 0 to 19 Years in the US.JAMA network open · 2023Article
- Clinical, laboratory, and chest radiographic characteristics of COVID-19 associated severe pediatric pneumonia.Saudi medical journal · 2022Article
- Vitamin D status can affect COVID-19 outcomes also in pediatric population.PharmaNutrition · 2022Review
- The impact of the COVID-19 pandemic on lifestyle behaviors in children and adolescents: an international overview.Italian journal of pediatrics · 2022Review
- COVID-19, anosmia, and ageusia in atopic children.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2022Article
- Clinical features and outcome of COVID-19 positive children from a tertiary healthcare hospital in Karachi.Journal of medical virology · 2021Article
- Cross-Sectional Survey on Long Term Sequelae of Pediatric COVID-19 among Italian Pediatricians.Children (Basel, Switzerland) · 2021Article
- Nutraceuticals in the Prevention of Viral Infections, including COVID-19, among the Pediatric Population: A Review of the Literature.International journal of molecular sciences · 2021Review
- Coronavirus Disease 2019 in Children.Frontiers in pediatrics · 2021Review
- COVID-19 in Children: Respiratory Involvement and Some Differences With the Adults.Frontiers in pediatrics · 2021Review
- Do children with severe acute respiratory infection need cohorting & isolation before screening for COVID-19?The Indian journal of medical researchArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
COVID-19 is less serious in children than in adults. However, respiratory management dominates the clinical picture of hospitalized COVID-19 even in children. In some case series, deterioration of the clinical picture wherein dyspnea, cyanosis, and the onset of acute respiratory distress syndrome (ARDS) emerged ~8-10 days after the onset of SARS-CoV-2 infection, which could rapidly progress to multiple organ failure and death. This review aimed to evaluate the characteristics of COVID-19 pneumonia in pediatric populations, beginning from its etiology and pathological mechanisms and closing with its clinical management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.